Search research articles
Contact Us
Filters
Showing results (121-130 of 155) with videos related to
Page
of 16
Sort By:
Neuro-Oncology
|
May 3, 2015
Toward precision medicine in glioblastoma: the promise and the challenges
Michael D Prados, Sara A Byron, Nhan L Tran, et al.
The New England Journal of Medicine
|
February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastoma
Mark R Gilbert, James J Dignam, Terri S Armstrong, et al.
Neuro-Oncology Advances
|
April 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial
Byram H Ozer, Adam L Cohen, Howard Colman, et al.
Molecular Cancer Therapeutics
|
August 16, 2020
Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen Therapy
Christian K Werner, Uchechi J Nna, Hanshi Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma
Kirit Singh, Kristen A Batich, Patrick Y Wen, et al.
Neuro-Oncology
|
April 5, 2022
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors
Benjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, et al.
Neuro-Oncology
|
September 21, 2014
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma
Marta Penas-Prado, Kenneth R Hess, Michael J Fisch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma
Howard Colman, Giuseppe Lombardi, Eric T Wong, et al.
Neurosurgery
|
June 20, 2019
Letter: When Less is More: Dexamethasone Dosing for Brain Tumors
Mary Jane Lim-Fat, Wenya Linda Bi, Janet Lo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 13, 2015
Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact
Pratheesh Sathyan, Pascal O Zinn, Anantha L Marisetty, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 155) with videos related to
Sort By:
Page
of 16
Neuro-Oncology
|
May 3, 2015
Toward precision medicine in glioblastoma: the promise and the challenges
Michael D Prados, Sara A Byron, Nhan L Tran, et al.
The New England Journal of Medicine
|
February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastoma
Mark R Gilbert, James J Dignam, Terri S Armstrong, et al.
Neuro-Oncology Advances
|
April 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial
Byram H Ozer, Adam L Cohen, Howard Colman, et al.
Molecular Cancer Therapeutics
|
August 16, 2020
Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen Therapy
Christian K Werner, Uchechi J Nna, Hanshi Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma
Kirit Singh, Kristen A Batich, Patrick Y Wen, et al.
Neuro-Oncology
|
April 5, 2022
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors
Benjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, et al.
Neuro-Oncology
|
September 21, 2014
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma
Marta Penas-Prado, Kenneth R Hess, Michael J Fisch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2025
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma
Howard Colman, Giuseppe Lombardi, Eric T Wong, et al.
Neurosurgery
|
June 20, 2019
Letter: When Less is More: Dexamethasone Dosing for Brain Tumors
Mary Jane Lim-Fat, Wenya Linda Bi, Janet Lo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 13, 2015
Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact
Pratheesh Sathyan, Pascal O Zinn, Anantha L Marisetty, et al.
Page
of 16